The health official behind the pause of the NHS’s puberty blocker trial is blocked from any further involvement amid accusations of bias.

THE NHS’ trial of puberty blockers for teenagers who think they are transgender has been put on hold at the last minute. Drugs and trials watchdog the Medicines and Healthcare products Regulatory ...

New York Attorney General Letitia James office is demanding that a Manhattan hospital resume the provision of puberty-blocking drugs and cross-sex hormones to gender dysphoric adolescents, which the ...

Too many non-experts are trying to influence the fate of the UK’s controversial puberty blocker trial and this is not helping the children involved, England’s chief medical officer has said. Last ...

The medicines regulator is suggesting the minimum age limit for trial should be raised to 14.

Recruitment of children for study delayed after MHRA warns that participants should be no younger than 14 ...

Regulator says Prof Jacob George will no longer be involved after gender-criticial social media posts from last year ...

The controversial Pathways trial assessing the effect of puberty blockers on young people with gender incongruence has been paused owing to “concerns related to the wellbeing of participants.” The UK ...

Office of New York's Letitia James resurrects legal argument Supreme Court rejected to compel hospital to resume medicalized ...

A leading endocrinologist with the Food and Drug Administration recommended pursuing approval for puberty blockers for youth with gender dysphoria despite acknowledging that they raised the risk of ...

Australia’s medicine safety officials have warned the government they are flying blind on the use of puberty blocker drugs ...

Sir Chris Whitty says ‘too many’ non-experts involved in puberty blocker debate - Kemi Badenoch and JK Rowling have expressed concern over a trial going ahead ...